TRODELVY ACCESS SUPPORT assists patients with insurance questions regarding benefits and coverage, and offers financial support guidance, including out-of-pocket cost assessments and alternate assistance options.
Monday-Friday, 9 AM-7 PM EST at 1-844-TRODELVY (1-844-876-3358).
If you are commercially or privately insured, the TRODELVY Savings Program* offers you savings on out-of-pocket expenses of TRODELVY 180-mg single-dose vials, up to $25,000 annually.
Terms and conditions apply.†
Your healthcare provider's office or TRODELVY ACCESS SUPPORT can help you apply.
Download the TRODELVY ACCESS SUPPORT Enrollment Form and then talk to your healthcare provider about the enrollment process:
*The TRODELVY Savings Program is not available to patients with any form of government insurance. Patients must meet certain eligibility criteria to qualify for this program. Once enrolled, the patient may pay $0 out-of-pocket for TRODELVY with maximum benefit of $25,000 per year.
†Click here to view the Terms & Conditions.
If you have government insurance, like Medicare, Medicaid, or VA, you will have access to TRODELVY ACCESS SUPPORT Case Managers who can provide you with information about third-party organizations that may be able to help with co-pays, deductibles, and insurance premiums related to your TRODELVY treatment.
If you have questions, call a TRODELVY ACCESS SUPPORT Case Manager at 1-844-TRODELVY (1-844-876-3358).
*Patients with Medicare or other government insurance who need assistance with cost-share requirements for TRODELVY may be eligible for co-pay or coinsurance assistance through an independent co-pay assistance foundation. Case managers can help patients assess their high-level eligibility for possible coverage for TRODELVY through an independent co-pay assistance foundation. If co-pay assistance needs are identified, the case managers can provide information about any available foundations. The foundation will determine the patient's eligibility for co-pay or coinsurance assistance based on their own criteria, completely independent of Gilead and its agents, and will contact the patient directly regarding the application process. Gilead and its agents make no guarantee regarding reimbursement for any service or item.
Eligible patients who are uninsured or underinsured can receive TRODELVY at no cost with help from the Gilead PAP.
To determine if you are eligible for the program, your healthcare provider will
If you have questions, call a TRODELVY ACCESS SUPPORT Case Manager at 1-844-TRODELVY (1-844-876-3358).
*Gilead PAP provides TRODELVY free of charge for eligible patients who are uninsured or underinsured. To qualify for assistance, patients must meet certain eligibility criteria.
TRODELVY support may vary based on application criteria and is subject to change or discontinuation. Prior authorizations and appeals must be submitted by a physician’s office.
TRODELVY® (sacituzumab govitecan-hziy) is a prescription medicine used to treat adults with:
It is not known if TRODELVY is safe and effective in people with moderate or severe liver problems or in children.
Do not receive TRODELVY if you have had a severe allergic reaction to TRODELVY. Ask your healthcare provider if you are not sure.
Allergic and infusion-related reactions which can be serious and life-threatening. Tell your healthcare provider or nurse right away if you get any of the following symptoms during your infusion of TRODELVY or within 24 hours after: swelling of your face, lips, tongue, or throat; hives; skin rash, itching, or flushing of your skin; fever; difficulty breathing or wheezing; lightheadedness, dizziness, feeling faint, or pass out; or chills or shaking chills (rigors).
Nausea and vomiting are common with TRODELVY and can sometimes be severe. Before each dose of TRODELVY, you will receive medicines to help prevent nausea and vomiting along with medicines to take home with instructions about how to take them. Call your healthcare provider right away if you have nausea or vomiting that is not controlled with the medicines prescribed for you. Your healthcare provider may decide to decrease your dose or stop TRODELVY if your nausea and vomiting is severe and cannot be controlled with anti-nausea medicines.
Before receiving TRODELVY, tell your healthcare provider about all of your medical conditions, including if you:
Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. Certain medicines may affect the way TRODELVY works.
The most common side effects of TRODELVY include decreased white blood cell (leukocyte and lymphocyte) and red blood cell counts, feeling tired or weak, hair loss, constipation, increased sugar levels in the blood, decreased protein levels (albumin) in the blood, decreased appetite, changes in kidney function test, increased levels of enzyme called alkaline phosphatase in the blood (test for liver or bone problems), and decreased levels of magnesium, potassium, and sodium in the blood.
These are not all of the possible side effects of TRODELVY. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
Please click to see Important Facts about TRODELVY, including Important Warning.